MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
Share
Topic Area: Press Release
Recent Posts
Florida Assisted-Living Facilities No Longer Required To Test Staff For COVID
Federal guidelines require nursing homes to continue testing
9/23/2020
Pandemic Hastening Closure Of Some Urban Hospitals
COVID has worsened the situation for already weakened hospitals
9/23/2020
Georgia Blocks ‘Granny Cam’ Legislation
Some in the long-term care industry have opposed cameras
9/23/2020
Blog
Tackling the Pandemic with Environmental Monitoring
The benefits of temperature and environmental monitoring are twofold
9/23/2020
Regulations, Codes & Standards Q&A: More On Power Strips
Brad Keyes discusses regulations related to power strips
9/23/2020
The Latest Coronavirus News & Resources »
SITE
RESOURCES
FREE
NEWSLETTER
News & Updates • Webcast Alerts • Building Technologies
Post Comment